Nuvectis Pharma, Inc. NVCT Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$26.44M-39.2% | -$19M+14.6% | -$22.26M-16.6% | -$19.09M-48.1% | ||
| $6.03M+24.2% | $4.86M+3.3% | $4.71M+176% | $1.71M— | ||
| -$16.01M-30.7% | -$12.25M+23.2% | -$15.95M-17.7% | -$13.56M— | ||
| —— | —— | $0— | $0— | ||
| $29.11M+150% | $11.65M-22.8% | $15.09M— | —— | ||
| —— | —— | -$867K— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Nuvectis Pharma, Inc. generate?
- Nuvectis Pharma, Inc. (NVCT) generated -$18.3M in operating cash flow over the trailing twelve months.
- Where does Nuvectis Pharma, Inc.'s cash flow data come from?
- Every line is extracted from Nuvectis Pharma, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.